Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555931 · ClinicalTrials.gov registry record · Phase 4
Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding
A Phase 4 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT01555931 is a Phase 4 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 61 participants.
The verdict
NCT01555931, a Phase 4 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) immediately after vaginal delivery compared to 4-8 weeks later. The investigators hypothesize there will be no difference in breastfeeding prevalence between the two groups.
Interventions
- DRUG Levonorgestrel-releasing intrauterine system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555931
The ClinicalTrials.gov registry entry for NCT01555931 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel-releasing intrauterine system is the first listed.
NCT01555931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01555931 about?
NCT01555931 is a clinical study titled "Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding". This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorge...
What is the current status of trial NCT01555931?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2012-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01555931?
The interventions under investigation include: Levonorgestrel-releasing intrauterine system (DRUG).
Who is sponsoring clinical trial NCT01555931?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.